SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-20-006317
Filing Date
2020-07-10
Accepted
2020-07-10 16:53:35
Documents
1
Period of Report
2020-08-20
Effectiveness Date
2020-07-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT admp-def14a_082020.htm DEF 14A 1433570
  Complete submission text file 0001387131-20-006317.txt   1434739
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36242 | Film No.: 201023644
SIC: 2834 Pharmaceutical Preparations